Cargando…
Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
Autores principales: | Marotte, H, Miossec, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833616/ http://dx.doi.org/10.1186/ar679 |
Ejemplares similares
-
Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, Hubert, et al.
Publicado: (2005) -
Shared epitope and rheumatoid arthritis severity: association with infliximab treatment in a postmarketing study
por: Marotte, H, et al.
Publicado: (2003) -
Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
por: Dénarié, Delphine, et al.
Publicado: (2017) -
Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
por: Mugnier, B, et al.
Publicado: (2004) -
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy
por: Marotte, Hubert, et al.
Publicado: (2008)